GLOBAL LIVE DESKS&P 500:7,743.41(+0.51%)FTSE 100:10,695.25(+0.14%)NIKKEI 225:66,364.20(+1.30%)BRENT CRUDE:$97.44(-2.77%)GOLD:$4,321.20(+0.54%)
RDU Global
🌐
🌐 Global Edition • Big Tech, Cloud & SemiconductorsRDU GLOBAL CORRESPONDENT
VERIFIED WIRE INTELLIGENCE

"Kalshi Suffers Another Court Setback as Judges Say Prediction Markets Must Follow Gambling Law"

A federal appeals court has dealt Kalshi another blow, ruling that its event-contract prediction markets cannot sidestep state gambling rules simply by framing bets as financial products. The decision sharpens a growing legal clash over whether federally regulated exchanges can offer contracts tied to politics, sports and other real-world outcomes without being treated like traditional bookmakers. The case now appears headed toward the Supreme Court, where the broader future of prediction markets may be decided.

Kalshi Suffers Another Court Setback as Judges Say Prediction Markets Must Follow Gambling Law

R

RDU Global Wire

Big Tech, Cloud & Semiconductors Desk

Washington, D.C., United States Just now (11:17 AM IST)•6 min read

A federal appeals court has dealt Kalshi another blow, ruling that its event-contract prediction markets cannot sidestep state gambling rules simply by framing bets as financial products. The decision sharpens a growing legal clash over whether federally regulated exchanges can offer contracts tied to politics, sports and other real-world outcomes without being treated like traditional bookmakers. The case now appears headed toward the Supreme Court, where the broader future of prediction markets may be decided.

Kalshi's bid to expand prediction markets across the United States suffered a fresh setback on Tuesday after judges ruled that the company cannot ignore state gambling laws while offering contracts tied to real-world events. The decision adds momentum to a widening legal fight that could determine whether prediction markets remain a niche financial instrument or become subject to the same restrictions that govern casinos and sportsbooks.

The ruling is significant because it strikes at the core of Kalshi's business model. The company has argued that its event contracts are federally regulated financial products, not wagers, and therefore should not be constrained by state-level gambling bans. Judges rejected that framing, saying the company's products still fall within the reach of gambling law when they are used to speculate on outcomes such as elections, sports results or other public events.

Legal Fault Line

The latest decision underscores a central question that has divided regulators, courts and market operators: when does a contract on a future event become a bet? Kalshi has maintained that its platform operates under the oversight of the Commodity Futures Trading Commission, giving it a federal shield against state interference. But states and tribal gaming interests have argued that the company is effectively offering legalized wagering under a different label.

That distinction matters far beyond Kalshi. Prediction markets have attracted growing attention from traders, technologists and policy makers because they can aggregate information quickly and sometimes more accurately than polls or expert forecasts. Yet the same features that make them useful for price discovery also make them vulnerable to gambling scrutiny, especially when contracts are linked to politically sensitive or entertainment-driven outcomes.

The court's reasoning suggests that federal registration alone may not be enough to override state gambling regimes. That creates a more difficult operating environment for any company hoping to scale event-based trading nationally. It also raises the possibility of a fragmented market, where some contracts are allowed in certain jurisdictions but prohibited in others, undermining the seamless exchange model that platforms like Kalshi have sought to build.

Supreme Court Pressure

The ruling increases the odds that the dispute will reach the Supreme Court. Kalshi has shown little sign of retreating from its legal strategy, and the company's defiance of state gambling laws has become a test case for the limits of federal pre-emption in emerging financial products. If the justices take up the matter, they would be asked to decide not only Kalshi's fate but also whether prediction markets deserve a distinct legal category at all.

For the broader technology and market infrastructure sector, the case carries outsized importance. Prediction markets sit at the intersection of fintech, data analytics and regulated exchange design, making them part of a larger wave of software-driven financial innovation. A ruling that narrows their scope could chill investment in similar products. A ruling that favors Kalshi could open the door to a much larger market for event contracts, including products tied to politics, macroeconomic data and cultural events.

The stakes are especially high because the industry has been trying to move from novelty to mainstream use. Supporters say prediction markets can improve forecasting, provide hedging tools and create more transparent price signals. Critics counter that they can encourage speculative behavior, blur the line between investing and gambling, and invite regulatory arbitrage if companies shop for the most favorable legal venue.

Market Model At Risk

Kalshi's legal losses also highlight a broader tension in U.S. regulation: innovation often moves faster than the legal framework built to supervise it. The company's argument depends on the idea that a federally supervised exchange should be able to list contracts on real-world outcomes without being treated like a sportsbook. Judges, however, appear increasingly skeptical that a novel label can erase the underlying economic reality of the transaction.

That skepticism may resonate with regulators who have long warned that financial engineering cannot simply reclassify gambling activity. It may also embolden states that want to preserve their authority over betting markets, particularly as online wagering expands and the line between entertainment and speculation becomes harder to police.

For now, Kalshi remains in the fight, but the legal terrain has become steeper. Each loss narrows the company's room to maneuver and strengthens the argument that prediction markets need either a clearer federal statute or a definitive Supreme Court ruling. Until then, the sector will remain caught between innovation and prohibition, with the outcome likely to shape the next phase of event-driven trading in the United States and beyond.

Editorial & Verification Notice

Reported by RDU Global Correspondent. Formatted and verified using real-time institutional and journalistic wire feeds. Independent reporting adhering to the RDU Global Editorial Code of Conduct.

Entity Intelligence & Connected Dossiers

Cross-referenced topic files, verified public records, and institutional tracking

Knowledge Graph
🏢Companies & Institutions:
📍Locations & Geopolitics:

Related Coverage

Big Tech, Cloud & Semiconductors

Hegseth’s Low-Testosterone Screening Plan Could Flag Up to a Quarter of the Army, Raising Medical and Readiness Concerns

A proposed low-testosterone screening initiative associated with Defense Secretary Pete Hegseth is drawing scrutiny from medical experts and military observers after estimates suggested it could identify as many as 25 percent of Army personnel. Clinicians say blanket screening is not supported by evidence and could produce false positives, unnecessary treatment, and avoidable disruption across the force.

18 Oct 2026, 05:00 PM IST
Big Tech, Cloud & Semiconductors

Google’s Android Laptop Push Shows the Platform Still Has a Long Way to Go

Google’s latest attempt to bring Android to laptops underscores both the ambition and the limits of the company’s cross-device strategy. While the idea of a familiar mobile operating system on larger screens is appealing, the early reality suggests Android laptops still feel more like Android than a true desktop alternative.

18 Oct 2026, 05:00 PM IST
Big Tech, Cloud & Semiconductors

RFK Jr. Reportedly Urges FDA to Tolerate Unproven Peptides, Raising Safety and Oversight Concerns

Robert F. Kennedy Jr. has reportedly proposed that the Food and Drug Administration take a lighter-touch approach toward unproven peptide products, according to a new report. The move comes as FDA scientists say none of the popular peptide drugs have been proven safe or effective, intensifying debate over consumer protection, medical evidence, and regulatory authority.

18 Oct 2026, 05:00 PM IST